Executive Director, Global Medical Lead (LC-FAOD, MPS VII and MPS IIIA)

Medical Doctor (MD) required. MD, PhD strongly preferred.  7+ years of combined industry and academic experience preferred. Board Certification or equivalent in Clinical/Biochemical Genetics or Neurology preferred

Proven expertise in the management of patients with inherited metabolic and/or neurodegenerative rare diseases

Recognized scientific authority with the ability to engage in advanced scientific and clinical discussions with both internal and external experts

Proven leadership skills including a passion for collaboration and understanding all stakeholder perspectives to drive alignment and decision-making

High aptitude for attention to detail, commitment to high-quality work, and a sense of passion and urgency to achieve goals and improve the lives of patients

Proven ability to take initiative and drive successful execution of complex projects

Ultragenyx is seeking an experienced physician leader to serve as Executive Director, Global Medical Affairs & Strategy, providing strategic medical leadership across key rare disease programs, including LC‑FAOD, MPS VII, and MPS IIIA.

In this role, you will guide global medical strategy for both approved therapies (Dojolvi and Mepsevii) and an investigational AAV gene therapy for MPS IIIA. You will shape and drive integrated evidence generation, scientific communications, external engagement, global launch preparation, and lifecycle strategy across a diverse and evolving portfolio.

Reporting to the VP, Global & US Medical Affairs and Strategy, the Executive Director will operate as a trusted scientific and strategic leader—collaborating cross‑functionally, influencing decisively, and navigating the complexities of metabolic and neurodegenerative genetic diseases. This is a high‑impact, career‑defining opportunity for a medical affairs leader passionate about advancing the future of rare disease medicine.

ultra

innovative – Tackle rare and dynamic challenges